Epinephrine Impurity 8 | CAS 139183-81-6 - Request Quote
Epinephrine Impurity 8
| SZ CAT No: | SZ-E037025 |
| CAS No | 139183-81-6 |
| Mol.F. | C9H13NO6S |
| Mol.Wt. | 263.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Epinephrine Impurity 8 is chemically (R)-1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethyl hydrogen sulfate. Epinephrine Impurity 8 is supplied with detailed characterization data compliant with regulatory guideline. Epinephrine Impurity 8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Epinephrine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 139183-81-6
Purchase 139183-81-6
Order 139183-81-6
Enquire 139183-81-6
price of 139183-81-6
139183-81-6 Supplier
139183-81-6 Manufacturer
139183-81-6 Exporter
buy high quality Epinephrine Impurity 8
Purchase Epinephrine Impurity 8
Epinephrine Impurity 8 suppliers
Epinephrine Impurity 8 manufacturers
Epinephrine Impurity 8 price
Order Epinephrine Impurity 8
Enquire Epinephrine Impurity 8
Epinephrine Impurity 8 cost
Epinephrine Impurity 8 Supplier
Epinephrine Impurity 8 Distributor
Epinephrine Impurity 8 for Method Validation
Epinephrine Reference Standard
Epinephrine Impurity 8 for ANDA Filing
Epinephrine Impurity 8 for Forced Degradation Studies
Epinephrine Impurity 8 Identification Standards
Epinephrine Impurity 8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


